Examples of FDA-approved markers are the prostate-specific antigen (PSA) for prostate cancer screening and carbohydrate antigen 125 (CA 125) for disease and therapy monitoring in ovarian cancer patients. This evidence concerns the gene KLK3 and Familial prostate cancer.